Home » Newsletters » BioWorld Asia

BioWorld Asia

Nov. 8, 2000

View Archived Issues

Arpida Raises $23M In 2nd Round To Fund Antimicrobial Programs

SynGenix Follows Glaxo Deal With Plan For Funding Round

Meristem Aquarius Sedaherb, Adds New Plant Technologies

MMI Group Raises $5M, Plans To Increase Incubation Services

Farmers, Grain Traders Add To EU Debate On GM Organisms

Affymetrix Gains Favorable UK Ruling In Oxford Gene Conflict

Correction (Article Updated in Database)

Cantab Shares Rebound On Talk Of Potential Merger, Acquisition

NSW University Developing Anti-Angiogenesis Compound

Environmentalists Want Biotech Held Liable For Illicit GM Foods

Israeli Firm Ventures Overseas, Leads $13M IDM Investment

Other News To Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 27, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.